The Mouse Trap: How Well Do Mice Model Human Immunology?

The Mouse in Biomedical Research

Volumn 4, Issue , 2007, Pages 303-312

  Hughes, Christopher C W ^a   Mestas, Javier ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84875390191     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369454-6/50093-5     Document Type: Chapter

References (123)

1. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 2002, 296:1323-1326.
2. Bankert R.B., Egilmez N.K., Hess S.D. Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol 2001, 22:386-393.
3. Barnaba V., Watts C., de Boer M., Lane P., Lanzavecchia A. Professional presentation of antigen by activated human T cells. Eur J Immunol 1994, 24:71-75.
4. Bielekova B., Richert N., Howard T., Blevins B., Markovic-Plese S., McCartin J., et al. Humanized anti-CD25 (daclizumab) inhibits dis-ease activity in multiple sclerosis patients failing to respond to interferon beta;. Proc Natl Acad Sci USA 2004, 101:8705-8708.
5. Brinkman-Van der Linden E.C., Angata T., Reynolds S.A., Powell L.D., Hedrick S.M., Varki A. CD33/Siglec-3 binding specificity, expres-sion pattern, and consequences of gene deletion in mice. Mol Cell Biol 2003, 23:4199-4206.
6. Buckley R.H. Immunodeficiency diseases, in Fundamental Immunology 1999, 1427-1453. Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
7. Chapoval A.I., Ni J., Lau J.S., Wilcox R.A., Flies D.B., Liu D., et al. B7-H3: a costimulatory molecule for T cell activation and IFN- gamma; pro-duction. Nat Immunol 2001, 2:269-274.
8. Choo J.K., Seebach J.D., Nickeleit V., Shimizu A., Lei H., Sachs D.H., Madser J.D. Species differences in the expression of major histo-compatibility complex class II antigens on coronary artery endothelium: implications for cell-mediated xenoreactivity. Transplantation 1997, 64:1315-1322.
9. Chu D.H., van Oers N.S., Malissen M., Harris J., Elder M., Weiss A. Pre-T cell receptor signals are responsible for the down-regulation of Syk protein tyrosine kinase expression. J Immunol 1999, 163:2610-2620.
10. Chun H.J., Zheng L., Ahmad M., Wang J., Speirs C.K., Siegel R.M., et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002, 419:395-399.
11. Conley M.E., Rohrer J., Rapalus L., Boylin E.C., Minegishi Y. Defects in early B-cell development: comparing the consequences of abnor-malities in pre-BCR signaling in the human and the mouse. Immunol Rev 2000, 178:75-90.
12. Copeland S., Warren H.S., Lowry S.F., Calvano S.E., Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol 2005, 12:60-67.
13. Correa I., Plunkett T., Vlad A., Mungul A., Candelora-Kettel J., Burchell J.M., et al. Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology 2003, 108:32-41.
14. Crocker P.R., Jefferies W.A., Clark S.J., Chung L.P., Gordon S. Species heterogeneity in macrophage expression of the CD4 antigen. J Exp Med 1987, 166:613-618.
15. Crommie D., Rosen S.D. Biosynthesis of GlyCAM-1, a mucin-like ligand for L-selectin. J Biol Chem 1995, 270:22614-22624.
16. Crowle A.J. Delayed hypersensitivity in the mouse. Adv Immunol 1975, 20:197-264.
17. Cunliffe R.N., Rose F.R., Keyte J., Abberley L., Chan W.C., Mahida Y.R. Human defensin 5 is stored in precursor form in normal Paneth cells and is expressed by some villous epithelial cells and by metaplastic Paneth cells in the colon in inflammatory bowel disease. Gut 2001, 48:176-185.
18. Daeron M. Fc receptor biology. Annu Rev Immunol 1997, 15:203-234.
19. Davis PH., Stanley S.L. Breaking the species barrier: use of SCID mouse-human chimeras for the study of human infectious diseases. Cell Microbiol 2003, 5:849-860.
20. Del Prete G., De Carli M., Almerigogna F., Giudizi M.G., Biagiotti R., Romagnani S. Human IL-10 is produced by both type 1 helper (Thl) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993, 150:353-360.
21. + T cell alloactivation. J Exp Med 1999, 190:555-566.
22. Doeing D.C., Borowicz J.L., Drockett E.T. Gender dimorphism in differential peripheral blood leukocyte counts in mice using cardiac, tail, foot, and saphenous vein puncture methods. BMC Clin Pathol 2003, 3:3.
23. Dumonde D.C., Pulley M.S., Paradinas F.J., Southcott B.M., O'Connell D., Robinson M.R., et al. Histological features of skin reactions to human lymphoid cell line lymphokine in patients with advanced cancer. J Pathol 1982, 138:289-308.
24. Dutronc Y., Porcelli S.A. The CD1 family and T cell recognition of lipid antigens. Tissue Antigens 2002, 60:337-353.
25. Elbe A., Foster C.A., Stingl G. T-cell receptor alpha; beta; and gamma; delta; T cells in rat and human skin-are they equivalent?. Semin Immunol 1996, 8:341-349.
26. Elder M.E., Skoda-Smith S., Kadlecek T.A., Wang F., Wu J., Weiss A. Distinct T cell developmental consequences in humans and mice expressing identical mutations in the DLAARN motif of ZAP-70. J Immunol 2001, 166:656-661.
27. Ensminger S.M., Spriewald B.M., Fischlein T., Weyand M., Morris P.J., Wood K.J. Mouse endothelial CD40 expression does not play a role during the development of transplant arteriosclerosis. Endothelium 2003, 10:111-117.
28. Farrar J.D., Smith J.D., Murphy T.L., Leung S., Stark G.r., Murphy K.M. Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat Immunol 2000, 1:65-69.
29. Fischer A., Cavazzana-Calvo M., De Saint Basile G., DeVillartay J.P., DiSanto J.P., Hivroz C., et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 1997, 15:93-124.
30. Flynn J.L., Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001, 19:93-129.
31. Freitas R. Lymphatic system. Nanomedicine, Vol. I: Basic Capabilities 1999, Landes Bioscience, Georgetown, TX.
32. + regulatory T cell func-tion. J Exp Med 2002, 196:851-857.
33. Gao J.L., Murphy P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J Biol Chem 1993, 268:25395-25401.
34. Geijtenbeek T.B., Torensma R., van Vliet S.J., van Duijnhoven G.C., Adema G.J., van Kooyk Y., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-585.
35. Geissmann F., Dieu-Nosjean M.C., Dezutter C., Valladeau J., Kaval S., Leborqne M., et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002, 196:417-430.
36. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., et al. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat Immunol 2002, 3:583-590.
37. Gordon C.J., Grafton G., Wood P.M., Larche M., Armitage R.J. Modelling the human immune response: can mice be trusted? [Commentary]. Curr Opin Pharmacol 2001, 1:431-435.
38. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003, 4:261-268.
39. Hagan P. IgE and protective immunity to helminth infections. Parasite Immunol 1993, 15:1-4.
40. Heinz S., Haehnel V., Karaghiosoff M., Schwarzfischer L., Muller M., Krause S.W., et al. Species-specific regulation of Toll-like receptor 3 genes in men and mice. J Biol Chem 2003, 278:21502-21509.
41. Heremans H., Dillen C., Groenen M., Martens E., Biliau A. Chronic relapsing experimental autoimmune encephalomyelitis (CREAE) in mice: enhancement by monoclonal antibodies against interferon- gamma;. Eur J Immunol 1996, 26:2393-2398.
42. Karmann K., Hughes C.C., Schechner J., Fanslow W.C., Pober J.S. CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995, 92:4342-4346.
43. Kaufmann S.H. gamma; delta; and other unconventional T lymphocytes: what do they see and what do they do?. Proc Natl Acad Sci USA 1996, 93:2272-2279.
44. Kaufmann S.H. How can immunology contribute to the control of tuberculosis?. Nat Rev Immunol 2001, 1:20-30.
45. Kemper C., Verbsky J.W., Price J.D., Atkinson J.P. T-cell stimula-tion and regulation: with complements from CD46. Immunol Res 2005, 32:31-44.
46. + regulatory T cells. Novartis Found Symp 2003, 252:45-52. discussion 52-4, 106-14.
47. + T lymphocytes in a B7-dependent fashion. J Immunol 2002, 169:6154-6161.
48. Lanier L.L. NK cell receptors. Annu Rev Immunol 1998, 16:359-393.
49. Lenschow D.J., Walunas T.L., Bluestone J.A. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996, 14:233-258.
50. Leonard W.J. Type I cytokines and interferons and their receptors, in Fundamental Immunology 1999, 741-774. Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
51. Li Q., Lifson J.D., Duan L., Schacker T.W., Reilly C., Carlis J., et al. Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection. J Infect Dis 2005, 192:1269-1276.
52. Lombardi G., Hargreaves R., Sidhu S., Imami N., Lightstone L., Fuller-Espie S., et al. Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals. J Immunol 1996, 156:2769-2775.
53. Lublin F.D., Knobler R.L., Kaiman B., Goldhaber M., Marini J., Perrault M., et al. Monoclonal anti- gamma; interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity 1993, 16:267-274.
54. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003, 198:513-520.
55. + T cells. J Immunol 2005, 174:4480-4484.
56. Martin A.M., Kulski J.K., Witt C., Pontarotti P., Christiansen F.T. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 2002, 23:81-88.
57. Martin R.M., Lew A.M. Is IgG2a a good Thl marker in mice?. Immunol Today 1998, 19:49.
58. McAdam A.J., Greenwald R.J., Levin M.A., Chernova T., Malenkovich N., Ling V., et al. ICOS is critical for CD40-mediated antibody class switching. Nature 2001, 409:102-105.
59. McDade T.W., Worthman C.M. Evolutionary process and the ecology of human immune function. Am J Human Biol 1999, 11:705-717.
60. Mestas J., Hughes C.C. Endothelial cell costimulation of T cell activation through CD58-CD2 interactions involves lipid raft aggregation. J Immunol 2001, 167:4378-4385.
61. Mestas J., Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 2004, 172:2731-2738.
62. Miller D.H., Khan O.A., Sheremata W.A., Blumhardt L.D., Rice G.P., Libonati M.A., et al. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 2003, 348:15-23.
63. Mills K.H. Regulatory T cells: friend or foe in immunity to infection?. Nat Rev Immunol 2004, 4:841-855.
64. Minegishi Y., Rohrer J., Coustan-Smith E., Lederman H.M., Pappu R., Campana D., et al. An essential role for BLNK in human B cell development. Science 1999, 286:1954-1957.
65. Monaco A.P. Chimerism in organ transplantation: conflicting experiments and clinical observations. Transplantation 2003, 75:13S-16S. (9 Suppl).
66. Monteiro R.C., Van De Winkel J.G. IgA Fc receptors. Annu Rev Immunol 2003, 21:177-204.
67. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
68. + memory T cells. Cell Immunol 1999, 194:150-161.
69. Murray A.G., Petzelbauer P., Hughes C.C., Costa J., Askenase P., Pober J.S. Human T-cell-mediated destruction of allogeneic dermal micro ves-sels in a severe combined immunodeficient mouse. Proc Natl Acad Sci USA 1994, 91:9146-9150.
70. Oehler M.K., Bicknell R. The promise of anti-angiogenic cancer therapy. Br J Cancer 2000, 82:749-752.
71. Ohnuma K., Yamochi Y, Uchiyama M., Nishibashi K., Iwatat S., Hosono O., et al. CD26 mediates dissociation of Tollip and IRAK-1 from caveolin-1 and induces upregulation of CD86 on antigen-presenting cells. Mol Cell Biol 2005, 25:7743-7757.
72. Olson T.S., Ley K. Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol 2002, 283:R7-R28.
73. Ouellette A.J., Selsted M.E. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J 1996, 10:1280-1289.
74. Pabst R., Gehrke I. Is the bronchus-associated lymphoid tissue (BALT) an integral structure of the lung in normal mammals, including humans?. Am J Respir Cell Mol Biol 1990, 3:131-135.
75. Pan J., Xia L., McEver R.P. Comparison of promoters for the murine and human P-selectin genes suggests species-specific and conserved mecha-nisms for transcriptional regulation in endothelial cells. J Biol Chem 1998, 273:10058-10067.
76. Panitch H.S., Hirsch R.L., Haley A.S., Johnson K.P. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987, 1:893-895.
77. Pappu R., Cheng A.M., Li B., Gong Q., Chiu C., Griffin N., et al. Requirement for B cell linker protein (BLNK) in B cell development. Science 1999, 286:1949-1954.
78. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005, 5:201-214.
79. Parkinson D.R., Fisher R.L., Rayner A.A., Paietta E., Margolin K.A., Weiss G.R., et al. Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen. J Clin Oncol 1990, 8:1630-1636.
80. + T cell response to Schistosoma mansoni. Exp Parasitol 1991, 73:110-116.
81. Pedotti R., De Voss L., Steinman J.J., Galli SJ. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol 2003, 24:479-484.
82. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell R.J., Marakovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
83. Pober J.S., Kluger M.S., Schechner J.S. Human endothelial cell pres-entation of antigen and the homing of memoryJeffector T cells to skin. Ann NY Acad Sci 2001, 941:12-25.
84. Rangarajan A., Weinberg R.A. Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer 2003, 3:952-959.
85. Rao N., Nguyen S., Ngo K., Fung-Leung W.P. A novel splice variant of interleukin-1 receptor (IL-lR) -associated kinase 1 plays a negative regu-latory role in Toll/IL-1R-induced inflammatory signaling. Mol Cell Biol 2005, 25:6521-6532.
86. Raulet D.H. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev Immunol 2003, 3:781-790.
87. Reddehase M.J., Podlech J., Grzimek N.K. Mouse models of cytomegalovirus latency: overview. J Clin Virol 2002, 25(Suppl 2):S23-S36.
88. Rehli M. Of mice and men: species variations of Toll-like receptor expression. Trends Immunol 2002, 23:375-378.
89. Risso A. Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity. J Leuk Biol 2000, 68:785-792.
90. Rogge L., Barberis-Maino L., Biffi M., Passini N., Presky D.H., Gubler U, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997, 185:825-831.
91. Roifman C.M., Zhang J., Chitayzt D., Sharfe N. A partial deficiency of interleukin-7R alpha; is sufficient to abrogate T-cell development and cause severe combined immunodeficiency. Blood 2000, 96:2803-2807.
92. Sachs D.H. Tolerance: of mice and men. J Clin Invest 2003, 111:1819-1821.
93. Satterthwaite A.B., Witte O.N. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol Rev 2000, 175:120-127.
94. Schneemann M., Schoedon G., Hofer S., Blau N., Guerrero L., Schaffner A. Nitric oxide synthase is not a constituent of the antimicrobial arma-ture of human mononuclear phagocytes. J Infect Dis 1993, 167:1358-1363.
95. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 1991, 30:694-700.
96. Shepherd F.A., Sridhar S.S. Angiogenesis inhibitors under study for the treatment of lung cancer. Lung Cancer 2003, 41(Suppl 1):S63-S72.
97. + hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 2003, 102:881-886.
98. Snapper C.M., Finkelman F.D. Immunoglobulin class switching, in Fundamental Immunology 1999, 831-861. Lippincott-Raven, Philadelphia. W.E. Paul (Ed.).
99. Sparano J.A., Fisher R.I., Sunderland M., Margolin K., Ernest M.L., Sznol M., et al. Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma. J Clin Oncol 1993, 11:1969-1977.
100. Steinman R.M., Mellman I. Immunotherapy: bewitched, bothered, and bewildered no more. Science 2004, 305:197-200.
101. Suh W.K., Gajewska B.U., Okada H., Gronski M.A., Bertram E.M., Dawicki W, et al. The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol 2003, 4:899-906.
102. Sultan P., Schechner J.S., McNiff J.M., Hochman P.S., Hughes C.C., Lorber M.I., et al. Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouseJhuman chimeras. Nat Biotechnol 1997, 15:759-762.
103. Sykes M. Mixed chimerism and transplant tolerance. Immunity 2001, 14:417-424.
104. 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997, 185:817-824.
105. Taams L.S., van Eden W, Wauben M.H. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential con-sequences for T cell activation and subsequent T cell-APC interactions. Eur J Immunol 1999, 29:1543-1550.
106. Tafuri A., Shahinian A., Bladt F., Yoshinaga S.K., Jordana M., Wakeham A., et al. ICOS is essential for effective T-helper-cell responses. Nature 2001, 409:105-109.
107. Thomas J.D., Sideras P., Smith C.I., Vorechovsky I., Chapman V, Paul WE. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 1993, 261:355-358.
108. Tibbetts M.D., Zheng L., Lenardo M.J. The death effector domain protein family: regulators of cellular homeostasis. Nat Immunol 2003, 4:404-409.
109. Tokugawa Y., Koyama M., Silver J. A molecular basis for species differences in Thy-1 expression patterns. Mol Immunol 1997, 34:1263-1272.
110. Trevani A.S., Chorny A, Salamone G., Vermeulen M., Gamberale R., Schettini J., et al. Bacterial DNA activates human neutrophils by a CpG-independent pathway. Eur J Immunol 2003, 33:3164-3174.
111. Unutmaz D., KewalRamani V.N., Littman D.R. G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models. Semin Immunol 1998, 10:225-236.
112. van der Merwe P.A. A subtle role for CD2 in T cell antigen recogni-tion. J Exp Med 1999, 190:1371-1374.
113. van Kooyk Y., Geijtenbeek T.B. A novel adhesion pathway that regulates dendritic cell trafficking and T cell interactions. Immunol Rev 2002, 186:47-56.
114. van Oosten B.W., Barkhof F., Truyen L., Boringa J.B., Bertelsmann F.W., von Blomberg B.M., et al. Increased MRI activity and immune acti-vation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996, 47:1531-1534.
115. Varki A. Loss of N-glycolylneuraminic acid in humans: mechanisms, consequences, and implications for hominid evolution. Am J Phys Anthropol Suppl 2001, 33:54-69.
116. Von Luttichau I.V., Notohamiprodjo M., Wechselberger A., Peters C., Henger A., Seliger C., et al. Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 2005, 14:329-336.
117. Waterston R.H., Lindblad-Toh K., Birney E., Rogers J., Abril J.F., Agarwal P., et al. Initial sequencing and comparative analysis of the mouse genome. Nature 2002, 420:520-562.
118. Webb J.R., Lee S.H., Vidal S.M. Genetic control of innate immune responses against cytomegalovirus: MCMV meets its match. Genes Immun 2002, 3:250-262.
119. Weinberg J.B. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 1998, 4:557-591.
120. Wood K.J. Passenger leukocytes and microchimerism: what role in tolerance induction?. Transplantation 2003, 75:17S-20S. (9 Suppl).
121. 1 integrin. Nature 1992, 356:63-66.
122. Zemlin M., Klinger M., Link J., Zemlin C., Bauer K., Engler J.A., et al. Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J Mol Biol 2003, 334:733-749.
123. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.